<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251202068202N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-10</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the effects of low-load resistance training with and without BFR in shoulder impingement syndrome</public_title>
      <acronym></acronym>
      <scientific_title>To compare the effects of low-load resistance training with and without blood flow restriction on thickness, strength and pain of shoulder girdle muscles in individuals with shoulder impingement syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87907</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The method used is balanced block randomization with a block size of 4. The unit of randomization is the individual participant. The study did not employ stratified randomization, meaning no specific stratification variables (such as age or disease severity) were used to create subgroups before randomization. The primary tool for implementing randomization was sequentially numbered, sealed, opaque envelopes. The random sequence was built by an independent researcher prior to the study's commencement. This was done by listing all possible combinations that would result in 2 allocations to Group A (LLRT) and 2 allocations to Group B (LLRT+BFR) within each block of 4 participants. This sequence was transcribed and placed into the sealed envelopes, Blinding description: This trial implements a structured blinding protocol where participants are blinded to their group assignment through allocation concealment using sequentially numbered, sealed, opaque envelopes, coupled with a sham procedure for the control group to mimic the sensory experience of the BFR cuff. The treating physiotherapist administering the interventions cannot be blinded due to the necessary application of the BFR technique. The principal investigator overseeing the trial remains blinded to group allocation during active data collection and analysis to prevent bias. Crucially, all outcome assessors are blinded: a clinical assessor, separate from the treating therapist, conducts all physical and questionnaire-based evaluations without knowledge of the assignment, and a radiologist performs all ultrasound measurements independently with no information on the participant's group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>shoulder impingement syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Low-load resistance training (LLRT) with Blood Flow Restriction (BFR). Participants in this group will perform exercises at 20-40% of 1RM. An active BFR cuff will be applied to the proximal arm and inflated to a pressure set at 50% of the individual's pre-determined Limb Occlusion Pressure (LOP) to partially restrict arterial inflow and venous return during exercise. This group will also receive standard passive physiotherapy (hot pack, TENS, ultrasound). Intervention 2: Control group: Low-load resistance training (LLRT) with sham Blood Flow Restriction (BFR). Participants in this group will perform exercises at 20-40% of 1RM. A sham BFR cuff will be applied to the proximal arm; it will be inflated to a minimal, non-therapeutic pressure to provide the sensory experience without creating meaningful blood flow restriction. This group will also receive standard passive physiotherapy (hot pack, TENS, ultrasound).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Bahram Tabatabaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 35 - Habibollah Aqighi Alley - North Kerman Street - Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1634869467</zip>
        <telephone>+98 915 655 1679</telephone>
        <email>tabatabaei.bah@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mostafa Rahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physiotherapy Section - Amiralam Hospital - Beginning of Saadi Street - Enghelab Street (Dorvazeh Dolat) - Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1145765111</zip>
        <telephone>+98 912 207 0616</telephone>
        <email>rahimim@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 40 to 60 years
Literacy in Persian
experiencing shoulder pain for a maximum of 3 months
Shoulder pain at night or during overhead activities greater than or equal to 3 based on VAS scale
Positive Painful arc test and at least three of the following tests: Neer- Hawkins-kennedy- Empty can- infraspinatus</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Contraindications for the use of BFR, including:• History of blood clots (DVT)• Blood pressure higher than 180 mmHg• Acute infection, peripheral vascular problems, varicose veins, or cancer.• History of hemorrhagic or thrombotic strokes.• History of arterial fibrillation
Simultaneous pain in both shoulders
Suffering from frozen shoulder
Positive drop arm test indicating a complete rotator cuff tear
History of surgery, fracture, or dislocation in the shoulder area
Use of anti-inflammatory drugs during the day while undergoing the physiotherapy course</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Impingement syndrome of shoulder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Low-load resistance training (LLRT) with Blood Flow Restriction (BFR). Participants in this group will perform exercises at 20-40% of 1RM. An active BFR cuff will be applied to the proximal arm and inflated to a pressure set at 50% of the individual's pre-determined Limb Occlusion Pressure (LOP) to partially restrict arterial inflow and venous return during exercise. This group will also receive standard passive physiotherapy (hot pack, TENS, ultrasound).</i_keyword>
      <i_keyword>Control group: Low-load resistance training (LLRT) with sham Blood Flow Restriction (BFR). Participants in this group will perform exercises at 20-40% of 1RM. A sham BFR cuff will be applied to the proximal arm; it will be inflated to a minimal, non-therapeutic pressure to provide the sensory experience without creating meaningful blood flow restriction. This group will also receive standard passive physiotherapy (hot pack, TENS, ultrasound).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Isometric muscle strength of the rotator cuff muscles (supraspinatus). Timepoint: pre and post intervention. Method of measurement: hand-held, fixed dynamometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Thickness of supraspinatus, infraspinatus, middle trapezius, and biceps muscles at rest. Timepoint: pre and post intervention. Method of measurement: B-mode ultrasonography (model: Supersonic MACH30).</sec_outcome>
      <sec_outcome>Night pain and pain while elevating the shoulder. Timepoint: pre and post intervention. Method of measurement: Numeric pain rating scale.</sec_outcome>
      <sec_outcome>Pain pressure threshold on 2 points (end of supraspinatus muscle and thenar area of ​​the affected side). Timepoint: pre and post intervention. Method of measurement: digital algometer.</sec_outcome>
      <sec_outcome>Functional pain and disability. Timepoint: pre and post intervention. Method of measurement: Shoulder Pain and Disability Index questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-20</approval_date>
        <contact_name>Research Ethics Committees of Amir A'lam Hospital Complex</contact_name>
        <contact_address>Amiralam Hospital- Beginning of Saadi Street-Enghelab Street (Dorvaze Dolat)-Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
